IBBR Publications

Found 30 results
Filters: Keyword is Cell Proliferation  [Clear All Filters]
Tran K, Risingsong R, Royce DB, Williams CR, Sporn MB, Pioli PA, Gediya LK, Njar VCO, Liby KT. The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer. Carcinogenesis. 2013 ;34(1):199-210.
Hyland LL, Twomey JD, Vogel S, Hsieh AH, Y Yu B. Enhancing biocompatibility of D-oligopeptide hydrogels by negative charges. Biomacromolecules. 2013 ;14(2):406-12.
Frescura VDal-Souto, Kuhn AWouters, Laughinghouse HDail, Paranhos JTerezinha, Tedesco SBosio. Post-treatment with plant extracts used in Brazilian folk medicine caused a partial reversal of the antiproliferative effect of glyphosate in the Allium cepa test. Biocell. 2013 ;37(2):23-8.
Jung K-Y, Samadani R, Chauhan J, Nevels K, Yap JL, Zhang J, Worlikar S, Lanning ME, Chen L, Ensey M, et al. Structural modifications of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione that improve selectivity for inhibiting the proliferation of melanoma cells containing active ERK signaling. Org Biomol Chem. 2013 ;11(22):3706-32.
Purushottamachar P, Godbole AM, Gediya LK, Martin MS, Vasaitis TS, Kwegyir-Afful AK, Ramalingam S, Ates-Alagoz Z, Njar VCO. Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer. J Med Chem. 2013 ;56(12):4880-98.
Yu B, Liu W, Yu W-M, Loh ML, Alter S, Guvench O, Mackerell AD, Da Tang L-, Qu C-K. Targeting protein tyrosine phosphatase SHP2 for the treatment of PTPN11-associated malignancies. Mol Cancer Ther. 2013 ;12(9):1738-48.